Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
8.62
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.38
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
52.67%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
4.17
EV to EBIT
7.51
EV to EBITDA
6.85
EV to Capital Employed
10.52
EV to Sales
3.08
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
140.00%
ROE (Latest)
43.33%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
12What is working for the Company
NET SALES(Q)
At HKD 483.42 MM has Grown at 117.95%
PRE-TAX PROFIT(Q)
At HKD 225.66 MM has Grown at 745.88%
NET PROFIT(Q)
At HKD 231.11 MM has Grown at 819.83%
ROCE(HY)
Highest at 97.67%
RAW MATERIAL COST(Y)
Fallen by -83.38% (YoY
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Qyuns Therapeutics Co., Ltd.
Net Sales
At HKD 483.42 MM has Grown at 117.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely positive
Net Sales (HKD MM)
Pre-Tax Profit
At HKD 225.66 MM has Grown at 745.88%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 231.11 MM has Grown at 819.83%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Raw Material Cost
Fallen by -83.38% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading






